Press Releases
Page 4 • 12 itemsAccess critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Thailand Emerges as ASEAN Medical Device Gateway as Market Set to Reach $18.6B by 2029
Thailand positions itself as Southeast Asia's medical device hub with WHX Bangkok 2026, targeting $18.6B regional MedTech market growing at 7.31% annually.
Yangtze River Pharmaceutical Group Quadruples International Revenue in 2025 Global Expansion
Yangtze River Pharmaceutical Group reports 4x international revenue growth, doubling global partnerships while exporting 100+ products to 40+ countries.
Soleno Therapeutics Faces Securities Fraud Lawsuit Over Alleged Sham Phase 3 Clinical Trials
Soleno Therapeutics hit with securities fraud allegations claiming company conducted fraudulent Phase 3 trials that led to FDA drug approval.
Newleos Begins Phase 1b Trial of NTX-2001 for Alcohol Use Disorder Treatment
Newleos doses first patient in Phase 1b study of NTX-2001, a TAAR1 partial agonist targeting alcohol use disorder, marking key development milestone.
Citius Oncology Ships First LYMPHIR International Order to Europe, Expanding Global Cancer Treatment Access
Citius Oncology ships first international LYMPHIR order to Europe through regional distribution partners, marking major milestone in global expansion.
EirGenix Expands Japan Biosimilar Strategy at CPHI Japan 2026 Amid Regulatory Support
EirGenix leverages Japan's supportive biosimilar regulatory framework and supply chain transformation to strengthen its strategic presence in the Japanese market.
TrialClinIQ Secures $150K Investment from Caduceus Capital to Transform Clinical Trial Recruitment with AI Technology
Houston-based TrialClinIQ raises $150K pre-seed funding and joins LAUNCH accelerator while opening $1.5M round to improve clinical trial access through AI.
Argo Biopharma Doses First Patient in Phase I Trial of siRNA Therapy BW-50218 for TTR-Related Disease
Argo Biopharma begins Phase I clinical trial of BW-50218, an siRNA therapeutic targeting transthyretin protein for rare disease treatment in Australia.
Claruvis Pharmaceutical's Retoxin Becomes World's First Approved Recombinant Botulinum Toxin Type A in China
China's NMPA approves Retoxin, the world's first recombinant botulinum toxin type A, marking a technological breakthrough in aesthetic medicine treatments.
Jyong Biotech Advances Market Access Strategy for Botanical Drug Botreso® and PCP Pipeline
Jyong Biotech (NASDAQ: MENS) updates market access strategies for botanical drugs Botreso® and PCP, establishing competitive advantages in plant-derived therapeutics.
Arcera Life Sciences Partners with Fosun Pharma for Neurodegenerative Disease R&D Collaboration
Arcera Life Sciences and Fosun Pharma establish strategic framework for neurodegenerative disease research, licensing, and technology development.
Samsung Bioepis Partners with ATLATL Innovation Center to Accelerate Asia-Pacific Biotech Development
Samsung Bioepis and ATLATL Innovation Center sign MoU to accelerate early-stage biotech innovation across Asia-Pacific region through open collaboration.